Press & News

People are different and so is their cancer, patients should be treated individually.

2cureX holds a virtual live-session on the 25th of February 2022 to present and discuss the Interim report for the fourth quarter of 2021.

February 23, 2022

IR

2cureX releases the Interim report for the fourth quarter of 2021 on the 24th of February 2022 and on the 25th of February CEO Fernando Andreu, CSO Ole Thastrup and CFO Kenneth G. Johansen will present and discuss the report and provide a status of the European roll-out of 2cureX’s first two IndiTreat products in metastatic colorectal cancer.

Please join us on the Webinar on the 25th of February at 14:00 (CET).

Link for registration: https://www.2curex.com/2curex-webinar-q4-2021/